CIK 0001501989 · Accelerated filer
CytomX Therapeutics, Inc.
Sign in to watch- Ticker
- CTMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273521219
- Phone
- 650.515.3185
- Business address
- 151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-03-02 | RAY DEBANJAN Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −5,515 | 14,710 | ||
| 2018-03-02 | RAY DEBANJAN Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −14,485 | 20,000 | ||
| 2018-03-01 | RAY DEBANJAN Chief Financial Officer | Option exercise | +13,000 | $1.26 | $16K | 17,741 |
| 2018-03-01 | RAY DEBANJAN Chief Financial Officer | Sale | −13,000 | $29.40 | $382K | 4,741 |
| 2018-03-01 | RAY DEBANJAN Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −13,000 | 20,225 | ||
| 2018-03-01 | McCarthy Sean A. President and CEO | Option exercise | +10,516 | $1.57 | $17K | 15,159 |
| 2018-03-01 | McCarthy Sean A. President and CEO | Option exercise | +9,000 | $1.13 | $10K | 24,159 |
| 2018-03-01 | McCarthy Sean A. President and CEO | Option exercise | +62 | $0.95 | $59 | 24,221 |
| 2018-03-01 | McCarthy Sean A. President and CEO | Sale | −19,578 | $29.43 | $576K | 4,643 |
| 2018-03-01 | McCarthy Sean A. President and CEO | Option exercise · Stock Option (Right to Buy) | −10,516 | 194,804 | ||
| 2018-03-01 | McCarthy Sean A. President and CEO | Option exercise · Stock Option (Right to Buy) | −9,000 | 328,143 | ||
| 2018-03-01 | McCarthy Sean A. President and CEO | Option exercise · Stock Option (Right to Buy) | −62 | 66,752 | ||
| 2018-02-28 | HUMPHREY RACHEL Chief Medical Officer | Option exercise | +23,840 | $6.61 | $158K | 54,074 |
| 2018-02-28 | HUMPHREY RACHEL Chief Medical Officer | Sale | −23,840 | $30.00 | $715K | 30,234 |
| 2018-02-28 | HUMPHREY RACHEL Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −23,840 | 239,140 | ||
| 2018-02-28 | GLUCK FREDERICK W Director | Sale | −3,819 | $30.00 | $115K | 292,824 |
| 2018-02-01 | RAY DEBANJAN Chief Financial Officer | Sale | −2,548 | $26.69 | $68K | 4,741 |
| 2018-01-24 | HUMPHREY RACHEL Chief Medical Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2018-01-24 | RAY DEBANJAN Chief Financial Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2018-01-24 | Kavanaugh William Michael CSO, Head Res.&Non-Clin. Dev. | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 |
Page 20 of 33 · 649 trades